Company intelligence / Profile preview

Chromologics

Copenhagen/Søborg, Denmarkchromologics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Chromologics has developed a proprietary fungal fermentation technology to produce sustainable, high-performance natural colorants. Their flagship product, Natu.Red®, has been tested in various food applications and offers superior stability and compatibility with dietary needs. The company remains in the R&D phase but has begun market testing and partnership development for its products. No clinical results as the company does not develop therapeutics.

Industry: Non-Drug Biotech

Drug pipeline

2 assets

Natu.Red

Commercial

Indications: Food coloring

1 more asset in the full pipeline.

Request access →

Partnerships

No major pharma or biotech partnerships reported; some venture capital partners include Novo Seeds/Novo Holdings, Blue Horizon Ventures, Nordic Food Tech Fund

Beyond the preview

Go deeper on Chromologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromologics.

Explore the full profile